Epidermolysis Bullosa Simplex has emerging NIH research funding with 1 grant totaling $1.7M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Epidermolysis Bullosa Simplex. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
4 clinical trials registered but no NIH-funded clinical or translational research grants found for epidermolysis bullosa simplex. Trials may be industry-sponsored or funded through non-NIH sources.
27 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for epidermolysis bullosa simplex. Existing research activity suggests this may be a viable area for grant applications.
Track funding opportunities for Epidermolysis Bullosa Simplex.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.